• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2013 Nov 10. doi: 10.1111/irv.12201. [Epub ahead of print]
An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands.
McDonald SA, Presanis AM, De Angelis D, van der Hoek W, Hooiveld M, Donker G, Kretzschmar ME.
Source

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Abstract
OBJECTIVES:

To estimate, using Bayesian evidence synthesis, the age-group-specific annual incidence of symptomatic infection with seasonal influenza in the Netherlands over the period 2005-2007.
METHODS:

The Netherlands population and age group distribution for 2006 defined the base population. The number of influenza-like illness (ILI) cases was estimated from sentinel surveillance data and adjusted for underascertainment using the estimated proportion of ILI cases that do not consult a general practitioner. The estimated number of symptomatic influenza (SI) cases was based on indirect evidence from the surveillance of ILI cases and the proportions of laboratory-confirmed influenza cases in the 2004/5, 2005/6 and 2006/7 respiratory years. In scenario analysis, the number of SI cases prevented by increasing vaccination uptake within the 65 + age group was estimated.
RESULTS:

The overall symptomatic infection attack rate (SIAR) over the period 2005-2007 was estimated at 2?5% (95% credible interval [CI]: 2?1-3?2%); 410 200 SI cases (95% CI: 338 500-518 600) were estimated to occur annually. Age-group-specific SIARs were estimated for <5 years at 4?9% (2?1-13?7%), for 5-14 years at 3?0% (2?0-4?7%), for 15-44 years at 2?6% (2?1-3?2%), for 45-64 years at 1?9% (1?4-2?5%) and for 65 + years at 1?7% (1?0-3?0%). Under assumed vaccination uptake increases of 5% and 15%, 1970 and 5310 SI cases would be averted.
CONCLUSIONS:

By synthesising the available information on seasonal influenza and ILI from diverse sources, the annual extent of symptomatic infection can be derived. These estimates are useful for assessing the burden of seasonal influenza and for guiding vaccination policy.

? 2013 John Wiley & Sons Ltd.
KEYWORDS:

Bayesian evidence synthesis, incidence, seasonal influenza, vacciation

PMID:
24209610
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24209610
 
Back
Top Bottom